REGENXBIO · 20 hours ago
Senior Director, Global Program Development Lead - DMD/Neuromuscular
Rockville, Maryland
Full-time
Onsite
Director/Executive
$235K/yr - $335K/yr
8+ years expREGENXBIO is an exceptional place to work, and they are seeking a Senior Director, Global Program Development Lead to drive strategic direction and execution in drug development. The role involves leading program strategy, cross-functional integration, and high-performing teams to ensure successful program outcomes in a dynamic environment.
BiopharmaBiotechnologyGeneticsTherapeutics
Responsibilities
Lead overall program strategy, accountable for an integrated Program Development Strategy, Target Product Profile (TPP), and lifecycle management plan aligned with corporate objectives and long-term portfolio goals to maximize asset value
Drive cross-functional strategic integration, ensuring scientific rigor and emerging clinical data, competitive intelligence, and evolving market dynamics inform program direction and critical decisions
Identify key development challenges and define strategic options across functions, including timelines, budgets, risks, and trade-offs, enabling timely, high-quality decision-making
Support business development activities, including opportunity assessment and due diligence; represent the program on Joint Steering Committees for partnered assets
Maintain external perspective and scientific credibility through engagement with KOLs, patient advocacy groups, and other external experts
Evolving and maturing the program’s external communications strategy in partnership with key groups, including the elements of scientific messaging, competitive positioning, and stakeholder alignment
Drive cross-functional program execution within a matrix organization, ensuring high-quality, on-time deliverables while aligning priorities and resources to maximize program value and proactively resolve critical challenges
Anticipate operational and strategic risks, establish contingency plans, and pressure-test assumptions, timelines, and budgets to maintain program agility and informed decision-making
Serve as the primary liaison between the Core Team and governance committees, presenting program materials with clear, data-driven recommendations and actionable options to support timely approvals
Build, influence, and sustain high-performing teams, guiding complex, high-stakes decisions without direct authority
Lead cross-functional teams to deliver high-impact program outcomes, challenging assumptions, timelines, and budgets while developing alternative scenarios to mitigate risk and maximize value
Own the quality, integrity, and timeliness of team outputs, ensuring company-level decisions are informed by robust, high-caliber data; set pace and priorities to achieve milestones in a highly competitive landscape
Serve as the program spokesperson, aligning stakeholders and communicating strategy, progress, and decisions clearly across internal and external audiences
Inspire innovation, scientific rigor, and creative problem-solving, fostering a culture of collaboration, continuous improvement, and boundary-less thinking
Coach and develop team members to achieve peak performance, cultivating accountability, skill growth, and collective achievement
Lead with pragmatism and clarity through ambiguity, charting the path forward and driving complex drug development decisions in fast-paced, dynamic environments
Travel up to 20%
Qualification
Required
Bachelor's degree required; advanced degree (MS, PhD, MBA) in life sciences or healthcare field preferred
Proven leader with 8+ years in pharmaceutical industry leadership, with a strong track record driving drug development programs through pivotal stages to commercialization; product launch and early commercialization experience is a strong plus
Strong understanding of drug development and commercialization processes, ideally within rare disease or gene therapy
Deep knowledge of neuromuscular diseases is highly desirable
The ability to work well under intense pressure, tight timelines, and in rapidly changing situations
Evidence of an entrepreneurial spirit and a capacity to find creative solutions to unexpected hurdles
Interacts effectively across teams with supporting REGENXBIO functions and disciplines using influencing, communication and relationship building skills
Commitment to anticipate, influence and direct change
Excellent listening and collaboration skills
Benefits
Annual bonus program
Education assistance
Retirement plan with employer match
Stock options at all levels
Summer hours
Company
REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$928.19MKey Investors
Vivo Capital
2025-05-19Post Ipo Debt· $150M
2024-03-06Post Ipo Equity· $140M
2021-01-06Post Ipo Equity· $230.3M
Leadership Team
Curran Simpson
President and CEO
Francesca Cook
Vice President, Global Pricing and Market Access
Recent News
2026-01-16
Longevity.Technology
2026-01-16
Company data provided by crunchbase